Translating a gene expression signature for multiple myeloma prognosis into a robust high-throughput assay for clinical use

Abstract excerpt

BACKGROUND: Widespread adoption of genomic technologies in the management of heterogeneous indications, including Multiple Myeloma, has been hindered by concern over variation between published gene expression signatures, difficulty in physician interpretation and the challenge of obtaining sufficient genetic material from limited patient specimens. METHODS: Since 2006, the 70-gene prognostic signature, developed...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Acute Myeloid Leukemia Research
• Share to Multiple Myeloma Research and Treatments